EQT Life Sciences
Boston, Massachusetts
EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced healthcare investors, targeting innovative life sciences and health care companies.
Founded:1986
Firm Location:Boston, Massachusetts • Brussels • Munich, Germany • Amsterdam, Netherlands • Germany • Belgium • United Kingdom • Oxford, United Kingdom
Investor Firms That Co-Invest with EQT Life Sciences
SR OneAbingworthFounder CollectiveVantagePoint Capital PartnersRoche Venture FundF-Prime Capital PartnersIllumina VenturesNovartis Venture FundStanley VenturesAtlas VentureYsios CapitalTheVentureCitySamsara BioCapitalQima VenturesPfizer Venture InvestmentsNew Enterprise Associates (NEA)Mott Family CapitalVivo CapitalKurma PartnersCatalio CapitalSanofi VenturesMission BioCapitalMP Healthcare Venture ManagementPontifax Venture CapitalForbionBioqube VenturesAndera PartnersAmzak Health InvestorsAtlantic BridgeEarlybird Venture CapitalM Ventures (Merck)INKEF CapitalSoffinova PartnersAmadeus Capital PartnersPivotal bioVenture PartnersVersant VenturesPolaris PartnersCanaan Partners5am VenturesOrbiMedSeroba Life Sciences
EQT Life Sciences Team
| INVESTORS | INTRO STRENGTH | SWEET SPOT (RANGE) | INVESTMENT LOCATIONS | TOP INVESTMENT CATEGORIES |
|---|---|---|---|---|
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Boston (MA) | Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Munich (Germany) | Investors in BioTech (Seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Germany | Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in United Kingdom | Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Belgium | Investors in BioTech (Series B) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in BioTech (Seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Brussels | Investors in BioTech (Seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in BioTech (Seed), Investors in BioTech (Pre-seed) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Oxford (United Kingdom) | Investors in BioTech (Seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Diverse Investors (Other Lists), Investors in BioTech (Series A) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in BioTech (Series A) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in United Kingdom | Investors in BioTech (Seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in BioTech (Seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Munich (Germany) | Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in BioTech (Series B) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in BioTech (Seed), Investors in AI (Seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in BioTech (Seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A) | |
| n/a | $25.0M ($11.0M - $65.0M) | Investors in Amsterdam (Netherlands) | Investors in BioTech (Seed), Investors in BioTech (Pre-seed) |